Tuberculosis therapy

Paul Nunn (London, United Kingdom)

Source: International Congress 2016 – Historical landmarks in respiratory medicine: contributions from the UK
Session: Historical landmarks in respiratory medicine: contributions from the UK
Session type: Symposium
Number: 2988
Disease area: Respiratory infections

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Paul Nunn (London, United Kingdom). Tuberculosis therapy. International Congress 2016 – Historical landmarks in respiratory medicine: contributions from the UK

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chloroquine as a potential adjunctive therapy in tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014


Tuberculosis
Source: Eur Respir Monogr 2014; 66: 112-127
Year: 2014


Tuberculosis
Source: Eur Respir Monogr 2014; 65: 37-47
Year: 2014


Tuberculosis
Source: ERS Course 2015
Year: 2015

Tuberculosis
Source: Breathe 2010; 6: 279
Year: 2010

Tuberculosis
Source: Eur Respir Rev 2014; 23: 36-39
Year: 2014



Tuberculosis
Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I
Year: 2012


Tuberculosis recurrence
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Tuberculosis in patients receiving treatment of TNF-alpha inhibitors
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Tuberculosis patients
Source: Eur Respir Monogr 2021; 90: 181-192
Year: 2021


Tuberculosis screening in patients receiving biological therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015

Collapse therapy in cavitary pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Tuberculosis - Basics in diagnosis and treatment
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017

Risk factors for disseminated tuberculosis
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Pulmonary Tuberculosis and latent Tuberculosis
Source: ERS Skills Course 2016
Year: 2016

Anti-TNF-alpha therapy in patients with latent tuberculosis incidence
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Cholecalciferol supplementation in patients taking anti tuberculosis treatment
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Efficiency of MDR-TB therapy with the use of thioureidoiminomethylpyridinii perchlorate
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016